O-linked N-acetylglucosamine (O-GlcNAc) addition is a type of post-translational modification that occurs on hundreds of proteins, including nuclear pore proteins, transcription factors, proteasome components and neuronal proteins. O-GlcNAc can be added onto and removed from serine or threonine residue by two evolutionally conserved enzymes: O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), respectively. Disruption of the O-GlcNAc cycling is involved in several human diseases, including diabetes mellitus and neurodegenerative diseases. One common signature of neurodegenerative diseases is the formation of protein aggregates, with toxic effects that could lead to neuronal degeneration and death. Human proteins that form protein aggregates in different neurodegenerative diseases have been expressed in the neurons or muscles of C. elegans to construct transgenic models. These human proteins include the following: different isoforms of Tau proteins (Alzheimers disease), beta-Amyloid (Alzheimers disease), Huntingtin (N-terminal)-polyglutamine fusion protein (Huntingtons disease), and yellow fluorescent protein (YFP)-polyglutamine fusion protein (PolyQ diseases). To investigate the effects of O-GlcNAc modification on proteotoxicity in a whole model organism, we crossed those Caenorhabditis elegans transgenic models into
ogt-1 or
oga-1 null mutant. The phenotypes of the transgenic animals were scored in wild type,
ogt-1 mutant, or
oga-1 mutant background. We found that the
ogt-1 mutation alleviated and the
oga-1 mutation worsened the phenotypes that are caused by the toxicity of those human proteins. In addition, in a Huntingtons disease model, we observed the same rescued phenotypes in
ogt-1;
oga-1 double mutant as in
ogt-1 single mutant, indicating that alterations of the phenotypes depend on O-GlcNAc modification. The level of transcript of the transgenes, measured by SYBR green real-time PCR, did not correlate with the alteration of phenotypes that we observed in different genetic backgrounds. Thus, regulation of some protein quality control systems by O-GlcNAc modification might be the underlying mechanism. There are two main protein degradation pathways: proteasome and autophagy. Our working hypothesis is that both degradation pathways might be up-regulated in
ogt-1 mutant and down-regulated in
oga-1 mutant.